3 Healthcare Mutual Funds to Grab on the Sector's 2024 Revival
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Oct 03 2024
0mins
Should l Buy ?
Source: NASDAQ.COM
Healthcare Sector Performance: The healthcare sector has struggled in 2023, rising only 0.3% compared to the S&P 500's 24% increase, despite significant technological advancements and a projected growth in health spending in the U.S. to $6.2 trillion by 2028.
Investment Opportunities: Investors are encouraged to consider healthcare mutual funds, which offer diversification and lower transaction costs, with three recommended funds showing strong performance and low expense ratios, including Janus Henderson Global Life Sciences (JNGLX) and Fidelity Select Pharmaceuticals Portfolio (FPHAX).
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
